Investigadores del Clínic-IDIBAPS han coordinado un estudio, publicado en la revista Gastroenterology, que demuestra que la cirrosis se caracteriza por la existencia de alteraciones marcadas en la co...
Read moreÓscar Fernández-Capetillo, jefe del Grupo de Inestabilidad Genómica, recibe 300.000 euros para estudiar el potencial de la proteína SETD8 como diana en cáncer. SETD8 se ha relacionado con e...
Read moreThe IDIBELL group led by Dr. Julián Cerón has received an “Ideas Semilla” grant from the Spanish Association Against Cancer (AECC). These grants are addressed at innovative projects tha...
Read moreAs you race towards the finish line in the development of your latest innovation, you must keep your eye on the activities of your competitors and potential technology partners. Being able to quickly ...
Read moreFundación MEDINA, the Drugs for Neglected Diseases initiative (DNDi) and Institut Pasteur Korea have been awarded a grant of EUR 995,000 from “la Caixa” Health Research 2020 program to identify n...
Read moreFelicidades a los farmacéuticos que siempre han cuidado de la salud de sus pacientes
Read moreLa toxina botulínica (bótox) está producido por una bacteria anaeróbica Clostridium botulinum y su mecanismo de acción implica la inhibición de la liberación de la acetilcolina a nivel de la un...
Read moreAlfa Laval ha pasado años trabajando de cerca con los clientes para que se ajusten al equipo de transferencia de calor adecuado a sus necesidades. Gran parte de esa experiencia está ahora disponible...
Read moreSartorius has joined the group of shareholders of the German Research Center for Artificial Intelligence (DFKI). The Göttingen-based life science group and DFKI have already been working together for...
Read moreThe international consortium Covid Human Genetic Effort has discovered mutations in eight genes involved in the interferon signalling pathway, the first element in the antiviral response, in young ...
Read moreFunds will support preparations for potential EU conditional approval of GB0139 in IPF and multiple new Phase 2 clinical trials
Read moreAsabys Partners, a venture capital firm and member of CataloniaBio & HealthTech, has participated in Medasense Biometrics Ltd’s €15.2-million Series C round of funding along with investors such as...
Read more